Skip to content

Clinical trials

Prostatic Neoplasms trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: Lithuania Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20061
20072
20091
20102
20112
20132
20142
20172
20211
20221
20231
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Terminated4
Enrolling by invitation2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ipsen3
Lithuanian University of Health Sciences3
Bayer2
Foresee Pharmaceuticals Co., Ltd.2
Kaunas University of Medicine2
Active Biotech AB1
Advanced Medical Diagnostics s.a.1
Amgen1
Central European Cooperative Oncology Group1
Edgaras Burzinskis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms26
Neoplasm Metastasis2
Adenocarcinoma1
Breast Neoplasms1
Disease1
Neoplasms1
Prostatic Neoplasms, Castration-Resistant1
Prostatitis1

Trials

Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.